267 related articles for article (PubMed ID: 16018743)
1. Bevacizumab in the treatment of colorectal cancer.
Mulcahy MF; Benson AB
Expert Opin Biol Ther; 2005 Jul; 5(7):997-1005. PubMed ID: 16018743
[TBL] [Abstract][Full Text] [Related]
2. Incidence and management of bevacizumab-related toxicities in colorectal cancer.
Saif MW; Mehra R
Expert Opin Drug Saf; 2006 Jul; 5(4):553-66. PubMed ID: 16774493
[TBL] [Abstract][Full Text] [Related]
3. Bevacizumab in the treatment of colorectal cancer.
Cilley JC; Barfi K; Benson AB; Mulcahy MF
Expert Opin Biol Ther; 2007 May; 7(5):739-49. PubMed ID: 17477810
[TBL] [Abstract][Full Text] [Related]
4. Integration of novel agents in the treatment of colorectal cancer.
Iqbal S; Lenz HJ
Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S32-9. PubMed ID: 15309512
[TBL] [Abstract][Full Text] [Related]
5. Can inhibition of angiogenic pathways increase the efficacy of intravenous 5-fluorouracil-based regimens?
Kabbinavar FF; Ellis LM
Clin Colorectal Cancer; 2004 Oct; 4 Suppl 2():S69-73. PubMed ID: 15479482
[TBL] [Abstract][Full Text] [Related]
6. Spotlight on bevacizumab in metastatic colorectal cancer.
McCormack PL; Keam SJ
BioDrugs; 2008; 22(5):339-41. PubMed ID: 18778115
[TBL] [Abstract][Full Text] [Related]
7. Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial.
Kabbinavar FF; Schulz J; McCleod M; Patel T; Hamm JT; Hecht JR; Mass R; Perrou B; Nelson B; Novotny WF
J Clin Oncol; 2005 Jun; 23(16):3697-705. PubMed ID: 15738537
[TBL] [Abstract][Full Text] [Related]
8. Integrating the anti-VEGF-A humanized monoclonal antibody bevacizumab with chemotherapy in advanced colorectal cancer.
Hurwitz H
Clin Colorectal Cancer; 2004 Oct; 4 Suppl 2():S62-8. PubMed ID: 15479481
[TBL] [Abstract][Full Text] [Related]
9. Anti-angiogenic therapies for metastatic colorectal cancer.
Wagner AD; Arnold D; Grothey AA; Haerting J; Unverzagt S
Cochrane Database Syst Rev; 2009 Jul; (3):CD005392. PubMed ID: 19588372
[TBL] [Abstract][Full Text] [Related]
10. [Anti-angiogenic treatment and colorectal cancer].
André T; Tournigand C; Abbas F; Louvet C; de Gramont A;
Bull Cancer; 2007 Jul; 94 Spec No():S211-9. PubMed ID: 17846007
[TBL] [Abstract][Full Text] [Related]
11. Bevacizumab: a review of its use in metastatic colorectal cancer.
McCormack PL; Keam SJ
Drugs; 2008; 68(4):487-506. PubMed ID: 18318567
[TBL] [Abstract][Full Text] [Related]
12. Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer.
Kabbinavar FF; Hambleton J; Mass RD; Hurwitz HI; Bergsland E; Sarkar S
J Clin Oncol; 2005 Jun; 23(16):3706-12. PubMed ID: 15867200
[TBL] [Abstract][Full Text] [Related]
13. Bevacizumab plus irinotecan-based regimens in the treatment of metastatic colorectal cancer.
Heinemann V; Hoff PM
Oncology; 2010; 79(1-2):118-28. PubMed ID: 21088438
[TBL] [Abstract][Full Text] [Related]
14. Spotlight on bevacizumab in advanced colorectal cancer, breast cancer, and non-small cell lung cancer.
Lyseng-Williamson KA; Robinson DM
BioDrugs; 2006; 20(3):193-5. PubMed ID: 16724868
[TBL] [Abstract][Full Text] [Related]
15. Vascular biology support for the use of bevacizumab in colorectal cancer.
Doggrell SA
Expert Opin Investig Drugs; 2004 Jun; 13(6):703-5. PubMed ID: 15174956
[TBL] [Abstract][Full Text] [Related]
16. Managing patients treated with bevacizumab combination therapy.
Gordon MS; Cunningham D
Oncology; 2005; 69 Suppl 3():25-33. PubMed ID: 16301833
[TBL] [Abstract][Full Text] [Related]
17. Bevacizumab combined with standard fluoropyrimidine-based chemotherapy regimens to treat colorectal cancer.
Hurwitz H; Kabbinavar F
Oncology; 2005; 69 Suppl 3():17-24. PubMed ID: 16301832
[TBL] [Abstract][Full Text] [Related]
18. Targeted therapy of colorectal cancer: clinical experience with bevacizumab.
Fernando NH; Hurwitz HI
Oncologist; 2004; 9 Suppl 1():11-8. PubMed ID: 15178811
[TBL] [Abstract][Full Text] [Related]
19. [New medications; bevacizumab].
Cohen AF; van Bronswijk H
Ned Tijdschr Geneeskd; 2006 Oct; 150(40):2194-5. PubMed ID: 17061430
[TBL] [Abstract][Full Text] [Related]
20. Targeting vascular endothelial growth factor in colorectal cancer.
Berlin JD
Oncology (Williston Park); 2002 Aug; 16(8 Suppl 7):13-5. PubMed ID: 12199627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
